Beranda8QQ • FRA
add
AbCellera Biologics Inc
Tutup sebelumnya
€2,46
Rentang hari
€2,44 - €2,44
Rentang tahun
€2,16 - €5,43
Kapitalisasi pasar
845,69 jt USD
Volume Rata-Rata
413,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 7,32 jt | -27,18% |
Biaya operasional | 59,85 jt | 139,67% |
Laba bersih | -36,93 jt | -20,97% |
Margin laba bersih | -504,30 | -66,12% |
Penghasilan per saham | -0,13 | -18,18% |
EBITDA | -56,93 jt | -24,36% |
Tarif pajak efektif | 23,36% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 670,36 jt | -15,75% |
Total aset | 1,41 M | -8,11% |
Total liabilitas | 301,51 jt | -11,93% |
Total ekuitas | 1,11 M | — |
Saham yang beredar | 294,67 jt | — |
Harga terhadap nilai buku | 0,65 | — |
Tingkat pengembalian aset | -16,25% | — |
Tingkat pengembalian modal | -19,58% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -36,93 jt | -20,97% |
Kas dari operasi | -29,97 jt | -250,56% |
Kas dari investasi | 52,10 jt | 251,49% |
Kas dari pembiayaan | 2,65 jt | 532,70% |
Perubahan kas bersih | 24,74 jt | 286,42% |
Arus kas bebas | -42,55 jt | -1.686,49% |
Tentang
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology firm that researches and develops human antibodies. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
Didirikan
2012
Kantor pusat
Situs
Karyawan
586
